1. News | 2015.06.24

   MERS-CoV in South Korea: the Institut Pasteur is supporting the response

   Since May 20, 2015, South Korea has been facing an outbreak of MERS-CoV that began with a traveler who returned from the Middle East. To date (as of June 24, 2015), there have been 179 cases and 27 deaths in Korea. As part of its global health mission, the Institut Pasteur is actively involved in monitoring the development of the outbreak, through its dedicated outbreak investigation taskforce.

2. News | 2015.07.08

   Eligo Bioscience receives EUR 2 Million from Seventure Partners to develop smart antibiotics

   Eligo Bioscience, located at the Institut Pasteur in Paris, announced it received an investment of €2m in a seed round financing from Seventure Partners, one of Europe’s leaders in financing innovation and visionary investor in the microbiome field since 2008.  

3. News | 2015.07.09

   The role of the microbiota in preventing allergies

   The microbiota is involved in many mechanisms, including digestion, vitamin synthesis and host defense. It is well established that a loss of bacterial symbionts promotes the development of allergies. Scientists at the Institut Pasteur have succeeded in explaining this phenomenon, and demonstrate how the microbiota acts on the balance of the immune system: the presence of microbes specifically...

4. News | 2015.07.09

   Towards a stronger partnership with Mexico

   On the occasion of the Franco-Mexican convention on Health, which took place this Friday, July 10th  at the French National Academy of Medicine, Dr. Mercedes Juan López, Minister of Health of Mexico and Christian Bréchot, President of the Institut Pasteur signed a memorandum of understanding to regulate and strengthen the Franco-Mexican scientific collaborations.

5. News | 2015.07.16

   Sara Eyangoh appointed to the TDR Scientific & Technical Advisory Committee (STAC)

   Sara Eyangoh, scientific Director and Head of the mycobacteriology unit of the Centre Pasteur du Cameroun has been officially appointed as a member of the Scientific & Technical Advisory Committee of the Special Programme for Research and Training in Tropical Diseases (TDR)

6. News | 2015.07.19

   First case of prolonged remission (12 years) in an HIV-infected child

   A young woman now aged 18 and a half, who at birth was HIV-infected via mother-to-child transmission, is in virological remission, despite not having taken any antiretroviral therapy for the last 12 years. This first case in the world of long-term remission in a child, monitored in the French ANRS pediatric cohort, is presented by Dr Asier Sáez-Cirión at the IAS conference in Vancouver.

7. News | 2015.07.29

   A MOOC in vaccinology

   A new MOOC developed by the Institut Pasteur will be launched on September 17, 2015. Thirty-one internationally renowned medicine professors, scientists, and public health professionals from many countries, will give a large overview of vaccinology: history, definitions, basic immunology, epidemiology, preclinical and clinical development, recent vaccines, and future challenges. This MOOC is...

8. News | 2015.08.02

   First Tripartite Fiocruz-IP-USP Hands-on Course Bioinformatics and Biostatistics

   The aim of this course is to provide students with theory and practical tools to analyze Next Generation Sequencing (NGS) data. The course is composed of a theory and practice lessons. In the first week theory sessions will cover the main kind of HTS analyses (re-sequencing and variant analysis, de-novo sequencing, transcriptomics, ChIP-Seq, metagenomics), in addition to some general...

9. News | 2015.08.05

   Train Africa’s scientists in crisis response

   Christian Bréchot, President of the Institut Pasteur, gives his personal take on the Ebola crisis, in Nature, on August 5, 2015.

10. News | 2015.09.06

    Malaria: a mutation counteracts resistance to chloroquine

    Since 1995, chloroquine is no longer used in French Guiana to treat P. falciparum malaria as it became resistant. The Institut Pasteur in French Guiana described for the first time, a reversal of this resistance in the parasite due to the acquisition of a new mutation. Published in the scientific journal PNAS, this finding is significant in optimizing the use and design of antimalarial drugs.

Pages